<DOC>
	<DOCNO>NCT01794897</DOCNO>
	<brief_summary>The effect Valacyclovir ( VAV ) augmentation placebo ( PLA ) adjuncts conventional antipsychotic drug treatment evaluate among patient schizophrenia expose herpes simplex virus type 1 ( HSV-1 ) . Hypothesis : Valacyclovir ( VAV ) augmentation improves ( ) cognitive ( b ) overall function among Herpes Simples Virus 1 ( HSV-1 ) expose early course schizophrenia patient .</brief_summary>
	<brief_title>Valacyclovir Augmentation Cognitive Functional Remediation Schizophrenia</brief_title>
	<detailed_description>Design : We propose randomize double blind placebo control study patient early course Schizophrenia ( SZ ) / schizoaffective disorder ( SZA ) patient expose HSV-1 , receive antipsychotic drug . The effect VAV augmentation PLA adjuncts conventional antipsychotic drug treatment evaluate . As outcome , evaluate clinical symptom , cognitive variable , overall function ( include social function ) side effect . The participant direct care Indian investigator study . Ratings perform blind research staff . We pre-screen HSV-1 exposure . There 2 week placebo run phase , 16 week augmentation 4 week follow identify post-treatment side effect .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Written inform consent . Both gender , age 1850 year Schizophrenia / schizoaffective disorder ( DSM IV ) . Stable dose antipsychotic &gt; 1 month , continue throughout study . Score 4 one item Positive Negative Syndrome Scale . Exposed HSV1 : serum antibody assay . Substance abuse past month/dependence past 6 month . History / current medical /neurological illness e.g. , epilepsy . Pregnancy . History immune disorder , HIV infection , receive immunesuppressants . Receiving regular antiviral therapy . History hypersensitivity Valacyclovir . Mental retardation define DSM IV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>